FSLBX
Price
$179.58
Change
+$0.12 (+0.07%)
Updated
Nov 18 closing price
Net Assets
1.28B
RYFNX
Price
$91.08
Change
+$0.06 (+0.07%)
Updated
Nov 18 closing price
Net Assets
9.72M
Interact to see
Advertisement

FSLBX vs RYFNX

Header iconFSLBX vs RYFNX Comparison
Open Charts FSLBX vs RYFNXBanner chart's image
Fidelity Select Brokerage & Inv Mgmt
Price$179.58
Change+$0.12 (+0.07%)
VolumeN/A
Net Assets1.28B
Rydex Financial Services A
Price$91.08
Change+$0.06 (+0.07%)
VolumeN/A
Net Assets9.72M
FSLBX vs RYFNX Comparison Chart in %
View a ticker or compare two or three
VS
FSLBX vs. RYFNX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSLBX is a Hold and RYFNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSLBX has more cash in the bank: 1.28B vs. RYFNX (9.72M). RYFNX pays higher dividends than FSLBX: RYFNX (0.79) vs FSLBX (0.67). FSLBX was incepted earlier than RYFNX: FSLBX (40 years) vs RYFNX (21 years). RYFNX (1.69) is less costly to investors than FSLBX (0.69). RYFNX is a more actively managed with annual turnover of: 280.00 vs. FSLBX (16.00). FSLBX has a lower initial minimum investment than RYFNX: FSLBX (0) vs RYFNX (2500). RYFNX annual gain was more profitable for investors over the last year : 0.52 vs. FSLBX (-4.07). FSLBX return over 5 years is better than : 113.24 vs. RYFNX (37.50).
FSLBXRYFNXFSLBX / RYFNX
Total Expense Ratio0.691.6442%
Annual Report Gross Expense Ratio0.691.6941%
Fund Existence40 years21 years-
Gain YTD-1.1774.922-24%
Front LoadN/A5%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.28B9.72M13,186%
Annual Yield % from dividends0.670.7986%
Returns for 1 year-4.070.52-781%
Returns for 3 years65.2014.11462%
Returns for 5 years113.2437.50302%
Returns for 10 years166.0279.63208%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PCSA0.310.03
+11.88%
Processa Pharmaceuticals
SLGN37.920.36
+0.96%
Silgan Holdings
PAYX109.96-0.52
-0.47%
Paychex
EMPD4.99-0.09
-1.87%
Empery Digital Inc
AVBP20.18-0.51
-2.46%
ArriVent BioPharma